Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix^® database

Author： Ganter Brigitte Snyder Ronald D Halbert Donald N Lee May D

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.7, Iss.7, 2006-10, pp. : 1025-1044

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The importance of applying toxicogenomics to increase the efficiency of drug discovery

By Barros Scott A

Pharmacogenomics, Vol. 6, Iss. 6, 2005-09 ,pp. : 547-550

Future Medicine

Access to resources Recommend Favorite

Toxicogenomics: an opportunity to optimise drug development and safety evaluation

By Kolaja Kyle L Kramer Jeffrey A

Expert Opinion on Drug Safety, Vol. 1, Iss. 3, 2002-09 ,pp. : 275-286

Informa Healthcare

Access to resources Recommend Favorite

Biospecific Interaction Analysis: A Tool for Drug Discovery and Development

By Gambari R.

American Journal of PharmacoGenomics, Vol. 1, Iss. 2, 2001-01 ,pp. : 119-135

Adis International

Access to resources Recommend Favorite

Toxicogenomics in drug safety assessment

By Hewitt Philip Walijew Alexandra

Pharmacogenomics, Vol. 9, Iss. 4, 2008-04 ,pp. : 379-382

Future Medicine

Access to resources Recommend Favorite

Psychiatric Drug Discovery and Development

By Maubach Karen

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. : 1571-1575

Informa Healthcare

Access to resources Recommend Favorite